SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 5, 2001
BIOTRANSPLANT INCORPORATED
(Exact name of registrant as specified in its charter)
DELAWARE 000-28324 04-3027191
----------------------------------- ----------------------------------- -------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
Building 75, Third Avenue
Charlestown Navy Yard
Charlestown, MA 02129
----------------------------------- ----------------------
(Address of principal (Zip Code)
executive offices)
Registrant's telephone number, including area code: (617) 241-5200
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On December 5, 2001, the Board of Directors of BioTransplant
Incorporated (the "Company") approved Amended and Restated By-Laws of the
Company. A copy of the Company's Amended and Restated By-Laws is attached to
this Current Report on Form 8-K as Exhibit 3.1.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: December 10, 2001 BIOTRANSPLANT INCORPORATED
By: /s/ Richard V. Capasso
----------------------------------
Richard V. Capasso
Vice President, Finance and Treasurer
EXHIBIT INDEX
EXHIBIT
NO. DESCRIPTION
------- -----------
3.1 Amended and Restated By-Laws